Loading...
Vsee Health Inc (VSEE) is not a strong buy at the moment for a beginner investor with a long-term strategy. The financial performance shows declining profitability, and there are no significant positive catalysts or trading signals to justify an immediate investment. Holding off for now is recommended.
The MACD is positive and expanding, suggesting a mild bullish momentum. However, the RSI is neutral at 70.933, and moving averages are converging, indicating no clear trend. The pre-market price is slightly below the R1 resistance level of 0.369, with a pre-market decline of -2.65%. Overall, the technical indicators do not suggest a strong buy signal.
Revenue increased by 18.67% YoY in Q3 2025, indicating some growth in top-line performance.
is also down -0.81%.
In Q3 2025, revenue increased to $3,980,655 (up 18.67% YoY). However, net income dropped to -$289,745 (down -99.46% YoY), EPS fell to -0.02 (down -99.44% YoY), and gross margin decreased to 52.08% (down -37.27% YoY). This indicates significant profitability challenges despite revenue growth.
No data available for analyst ratings or price target changes.
